Fexofenadine HCI
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Allergy
Conditions
Allergy
Trial Timeline
Nov 1, 2002 → Dec 1, 2002
NCT ID
NCT00547768About Fexofenadine HCI
Fexofenadine HCI is a approved stage product being developed by Sanofi for Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT00547768. Target conditions include Allergy.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00547768 | Approved | Completed |
Competing Products
20 competing products in Allergy